Anyone shopping for NMN supplements in India should note a sharp escalation in enforcement. On November 13, 2026, Maharashtra’s Food and Drug Administration (FDA) ran simultaneous inspections at 17 establishments across the state and seized about Rs 1.38 crore worth of health supplements and nutraceuticals containing nicotinamide mononucleotide (NMN) and magnesium acetyl taurate, two ingredients that the Food Safety and Standards Authority of India (FSSAI) has not approved for sale. The drive, reported by the Free Press Journal and Medical Dialogues, is the first large state-level action to follow FSSAI’s mid-2026 notices declaring NMN an unapproved ingredient.
Key takeaways on NMN supplements India
- NMN is not an approved ingredient for food supplements in India; FSSAI’s June 3, 2026 list showed no approved NMN ingredient or product.
- Maharashtra FDA seized about Rs 1.38 crore of nutraceuticals across six divisions on November 13.
- Brands named in reports include Rejuvance, Altibrain-S, Magladense and EQOQ.
- Samples have gone to laboratories to check whether products are substandard, unsafe or misbranded; no safety finding has been announced yet.
- Violators face licence suspension or cancellation and possible criminal proceedings, according to the state regulator.
Where the seizures happened
The crackdown covered the Pune, Nashik, Konkan, Nagpur, Amravati and Chhatrapati Sambhajinagar divisions and targeted manufacturers, distributors and sellers. According to the regulator’s figures as reported by the Free Press Journal, Nagpur accounted for the largest share of the nutraceutical haul. In Konkan, officials sealed stock at a Bhiwandi warehouse in Thane district run by Kanchan Pharma Pvt Ltd, which Medical Dialogues said was also linked to actions in Pune and Nagpur. Medical Dialogues put the statewide supplement total slightly higher, at about Rs 1.39 crore.
| Division | Nutraceuticals seized (reported) |
|---|---|
| Nagpur | Rs 57.30 lakh |
| Konkan (incl. Bhiwandi warehouse) | Rs 47.65 lakh |
| Pune | Rs 30.57 lakh |
| Other three divisions combined (by our calculation) | about Rs 2.5 lakh |
| Statewide total | about Rs 1.38 crore |
The same drive also targeted banned gutkha, scented tobacco and pan masala, lifting the overall seizure to about Rs 1.90 crore. In Pune, police registered five offences against seven accused in tobacco-related cases. Maharashtra FDA Commissioner Tukaram Mundhe said the aim was to ensure compliance with food safety rules and protect public health.
Why NMN is not allowed in Indian supplements
NMN is a precursor of NAD+, a coenzyme involved in cellular energy metabolism, and has been marketed worldwide as an anti-ageing or longevity supplement. In India, any ingredient that is not on FSSAI’s permitted lists must clear the non-specified food and food ingredients approval route, with a dossier covering safety data, toxicology, specifications and approvals elsewhere. NMN has not cleared that route. As NutraIngredients reported, an FSSAI notice dated July 24, 2026 described NMN as an “unapproved ingredient” and told e-commerce platforms to de-list a named product. Six NMN applications have been rejected and two were still under review at the time.
It is important to be precise about what this means. Unapproved is a regulatory status, not a finding that NMN is toxic. FSSAI has not published a specific safety rationale, and the Maharashtra regulator is still awaiting lab results on the seized products. The legal problem the state cited is that manufacturers allegedly made the products without mandatory product approval, and some marketers sold them without the right food category on their licences.
What the evidence on NMN actually shows
Animal studies on NAD+ precursors generated much of the longevity excitement, but human trials so far have been small and short, typically measuring blood NAD+ levels or modest metabolic markers rather than hard outcomes such as disease or lifespan. That gap between marketing and evidence is one reason regulators want a formal dossier before allowing sale. Consumers should also be wary of unregulated online sources, a pattern seen with other wellness products such as injectable peptides; see Health Canada Peptides Warning: Bacteria Found in Injectable Vials From Ottawa Store.
Market context: anti-ageing ingredients
Demand for longevity products explains why sellers keep testing the rules. According to Acumen Research and Consulting’s anti-ageing nutraceutical ingredients market report, the global market was worth USD 226.3 million in 2023 and is forecast to reach USD 426.4 million by 2032, a CAGR of 7.4%, with Asia-Pacific the fastest-growing region. The report also links growth to India’s expanding online consumer base, the same channel through which many NMN products have been sold.
What consumers and sellers should do now
- Buyers: check the label for an FSSAI licence number and the ingredient list; NMN or magnesium acetyl taurate on an Indian supplement label signals a product without approval.
- Current users: there is no recall or health alert yet, but anyone with symptoms or medical conditions should discuss any supplement with a doctor.
- Brands and e-commerce sellers: expect more de-listing notices and state inspections; FSSAI approval through the non-specified food route is the only compliant path.
FAQ
Is NMN banned in India?
NMN is not an approved ingredient for food supplements under FSSAI rules, so products containing it cannot legally be sold until an approval is granted. Regulators are now seizing such stock.
Which NMN products were seized in Maharashtra?
Reports name Rejuvance, Altibrain-S, Magladense and EQOQ, which allegedly contained NMN, magnesium acetyl taurate or both.
Is NMN unsafe?
No safety finding has been announced. The action is about missing approvals; lab tests on seized samples will show whether any are substandard or misbranded.
More from Pharmaceutical.
Sources: Maharashtra FDA as reported by Free Press Journal (November 14-15, 2026) and Medical Dialogues (November 17, 2026); FSSAI notice via NutraIngredients. Market data: Acumen Research and Consulting. Not medical advice. Last updated: November 17, 2026.

[…] supply chains. Readers following enforcement against unsafe products can see our reports on Maharashtra’s seizure of NMN supplements and India’s draft drug storage and distribution rules, along with more coverage in our […]